Cargando…

Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior

Several dynamic borrowing methods, such as the modified power prior (MPP), the commensurate prior, have been proposed to increase statistical power and reduce the required sample size in clinical trials where comparable historical controls are available. Most methods have focused on cross‐sectional...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Hongchao, Rizopoulos, Dimitris, Lesaffre, Emmanuel, van Rosmalen, Joost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356117/
https://www.ncbi.nlm.nih.gov/pubmed/35128780
http://dx.doi.org/10.1002/pst.2195
_version_ 1784763445049032704
author Qi, Hongchao
Rizopoulos, Dimitris
Lesaffre, Emmanuel
van Rosmalen, Joost
author_facet Qi, Hongchao
Rizopoulos, Dimitris
Lesaffre, Emmanuel
van Rosmalen, Joost
author_sort Qi, Hongchao
collection PubMed
description Several dynamic borrowing methods, such as the modified power prior (MPP), the commensurate prior, have been proposed to increase statistical power and reduce the required sample size in clinical trials where comparable historical controls are available. Most methods have focused on cross‐sectional endpoints, and appropriate methodology for longitudinal outcomes is lacking. In this study, we extend the MPP to the linear mixed model (LMM). An important question is whether the MPP should use the conditional version of the LMM (given the random effects) or the marginal version (averaged over the distribution of the random effects), which we refer to as the conditional MPP and the marginal MPP, respectively. We evaluated the MPP for one historical control arm via a simulation study and an analysis of the data of Alzheimer's Disease Cooperative Study (ADCS) with the commensurate prior as the comparator. The conditional MPP led to inflated type I error rate when there existed moderate or high between‐study heterogeneity. The marginal MPP and the commensurate prior yielded a power gain (3.6%–10.4% vs. 0.6%–4.6%) with the type I error rates close to 5% (5.2%–6.2% vs. 3.8%–6.2%) when the between‐study heterogeneity is not excessively high. For the ADCS data, all the borrowing methods improved the precision of estimates and provided the same clinical conclusions. The marginal MPP and the commensurate prior are useful for borrowing historical controls in longitudinal data analysis, while the conditional MPP is not recommended due to inflated type I error rates.
format Online
Article
Text
id pubmed-9356117
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-93561172022-10-14 Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior Qi, Hongchao Rizopoulos, Dimitris Lesaffre, Emmanuel van Rosmalen, Joost Pharm Stat Main Papers Several dynamic borrowing methods, such as the modified power prior (MPP), the commensurate prior, have been proposed to increase statistical power and reduce the required sample size in clinical trials where comparable historical controls are available. Most methods have focused on cross‐sectional endpoints, and appropriate methodology for longitudinal outcomes is lacking. In this study, we extend the MPP to the linear mixed model (LMM). An important question is whether the MPP should use the conditional version of the LMM (given the random effects) or the marginal version (averaged over the distribution of the random effects), which we refer to as the conditional MPP and the marginal MPP, respectively. We evaluated the MPP for one historical control arm via a simulation study and an analysis of the data of Alzheimer's Disease Cooperative Study (ADCS) with the commensurate prior as the comparator. The conditional MPP led to inflated type I error rate when there existed moderate or high between‐study heterogeneity. The marginal MPP and the commensurate prior yielded a power gain (3.6%–10.4% vs. 0.6%–4.6%) with the type I error rates close to 5% (5.2%–6.2% vs. 3.8%–6.2%) when the between‐study heterogeneity is not excessively high. For the ADCS data, all the borrowing methods improved the precision of estimates and provided the same clinical conclusions. The marginal MPP and the commensurate prior are useful for borrowing historical controls in longitudinal data analysis, while the conditional MPP is not recommended due to inflated type I error rates. John Wiley & Sons, Inc. 2022-02-06 2022 /pmc/articles/PMC9356117/ /pubmed/35128780 http://dx.doi.org/10.1002/pst.2195 Text en © 2022 The Authors. Pharmaceutical Statistics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Main Papers
Qi, Hongchao
Rizopoulos, Dimitris
Lesaffre, Emmanuel
van Rosmalen, Joost
Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
title Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
title_full Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
title_fullStr Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
title_full_unstemmed Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
title_short Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
title_sort incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior
topic Main Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356117/
https://www.ncbi.nlm.nih.gov/pubmed/35128780
http://dx.doi.org/10.1002/pst.2195
work_keys_str_mv AT qihongchao incorporatinghistoricalcontrolsinclinicaltrialswithlongitudinaloutcomesusingthemodifiedpowerprior
AT rizopoulosdimitris incorporatinghistoricalcontrolsinclinicaltrialswithlongitudinaloutcomesusingthemodifiedpowerprior
AT lesaffreemmanuel incorporatinghistoricalcontrolsinclinicaltrialswithlongitudinaloutcomesusingthemodifiedpowerprior
AT vanrosmalenjoost incorporatinghistoricalcontrolsinclinicaltrialswithlongitudinaloutcomesusingthemodifiedpowerprior